Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LFMD
#3191
LifeMD, Inc. Common Stock
2.6
7
-2.91%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.91%
Monatliche Änderung
-24.79%
6 month change
-58.86%
Jahresänderung
-46.06%
Vorheriger Schlusskurs
2.7
5
Open
2.6
7
Bid
Ask
Low
2.6
7
High
2.6
7
Volumen
41
Märkte
Aktien
Gesundheitswesen
LFMD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
LifeMD Inc
LifeMD, Inc. is a publicly traded American telehealth company. It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.
Nachrichten
Hims & Hers Expands Digital Health and Global Platform Strategy
LifeMD: Still My Favorite Bargain On The Market (NASDAQ:LFMD)
LifeMD: Pure Telehealth Play With In-House Pharmacy Integration (NASDAQ:LFMD)
BMO Capital raises Novo Nordisk stock price target to $57 on market outlook
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care
Jefferies baja calificación de GoodRx a Mantener por desafíos en segmento de recetas
Jefferies rebaja la calificación de GoodRx a Mantener debido a desafíos en el segmento de recetas
Hims & Hers And HIMZ: Short‑Term Pain From Novo, Long‑Term Opportunity Still Bright (HIMS)
BMO Capital mantiene el precio objetivo de Novo Nordisk en 46 dólares
Novo Nordisk stock price target maintained at $46 by BMO Capital
LifeMD mantiene calificación de Compra en H.C. Wainwright tras lanzar píldora Wegovy
LifeMD mantiene calificación de Compra en H.C. Wainwright tras lanzamiento de píldora Wegovy